Clinical TrialID 3557
Preliminary Study of Safety and Efficacy of Policosanol
NCT00312923
Dyslipidemia|HIV Infections
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3557
- Evidence Id
- 3557
- Core Evidence Id
- 3557
- Source Clinical Trial Id
- 3531
- Herb2 Clinical Trial Id
- HBCT003531
- Nct Id
- NCT00312923
- Title
- Preliminary Study of Safety and Efficacy of Policosanol
- Status
- Completed
- Phase
- Phase 2
- Study Result
- Yes
- Study Condition
- Dyslipidemia|HIV Infections
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Policosanol|DIETARY_SUPPLEMENT: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Crossover
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 54
- Outcome Measure
- LDL Cholesterol, Low density lipoprotein cholesterol, 12 weeks
- Sponsor Collaborator
- Rush University Medical Center|National Center for Complementary and Integrative Health (NCCIH)
- Funded By
- OTHER
- Location
- Rush University Medical Center, Chicago, Illinois, 60612, United States
- Other Id
- R21AT003077-01|R21AT003077-01
- Start Date
- 2005-09
- Primary Completion Date
- 2009-07
- Completion Date
- 2009-09
- First Posted
- 2006-04-11
- Results First Posted
- 2013-07-15
- Last Update Posted
- 2013-07-26
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00312923
- Title Cn
- Title En
- Preliminary Study of Safety and Efficacy of Policosanol
- Bilingual Status
- semi_complete